biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by amillionorbuston Jul 06, 2018 8:19pm

124 Views

Post# 28280378

RE:RE:RE:RE:do you think

JD, while I agree with your retort to Digi...it would sure be a vote of confidence if the SAB and BOD had more skin in the game. I couldn’t help but notice you avoided that part of his post (although I do recall you addressing it at another time). I did add to my position yesterday but the fact that all these insiders are not loading up right now gives me cause for concern.

Bullboard Posts

Global Tungsten Market and Supply Security